Trial News & Events

New therapy halts progression of Lou Gehrig’s disease in mice

Researchers at Oregon State University announced today that they have essentially stopped the progression of ALS, or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease. Read more here.